Eagle Pharmaceuticals
EGRX
$4.57
Share price
3.63%
Change (1 day)
-84.33%
Change (1 year)
Categories
Eagle Pharmaceuticals (EGRX) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $0.15 B
According to Eagle Pharmaceuticals 's latest financial reports the company's total liabilities are $0.15 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Eagle Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.17 B | 123.35% |
| 2021-12-31 | $77.27 M | 15.03% |
| 2020-12-31 | $67.17 M | -10.88% |
| 2019-12-31 | $75.38 M | -3.16% |
| 2018-12-31 | $77.84 M | -14.38% |
| 2017-12-31 | $90.91 M | 44.1% |
| 2016-12-31 | $63.09 M | 84.15% |
| 2015-12-31 | $34.26 M | |
| 2014-09-30 | $20.31 M | 26.58% |
| 2013-09-30 | $16.04 M | -25.48% |
| 2012-09-30 | $21.53 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $101.94 B | 66,626.45% | 🇺🇸 USA |
 Novartis NVS | $54.57 B | 35,622.79% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $51.04 B | 33,311.07% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 59,410.94% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $82.48 B | 53,887.38% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $57.22 B | 37,354.74% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $35.35 B | 23,039.51% | 🇮🇱 Israel |